Repligen Newsroom

Repligen Initiated at Hold by Canaccord Genuity

Dow JonesDec 17 11:10 ET

Repligen Analyst Ratings

BenzingaDec 17 11:00 ET

CCORF Initiates Repligen(RGEN.US) With Hold Rating, Announces Target Price $165

Moomoo NewsDec 16 16:31 ET

RBC Capital Reaffirms Their Buy Rating on Repligen (RGEN)

TipRanksDec 10 20:53 ET

RBC Lifts Price Target on Repligen to $207 From $205, Keeps Outperform Rating

MT NewswiresDec 9 07:14 ET

Repligen Analyst Ratings

BenzingaNov 14 08:45 ET

Wolfe Research Initiates Repligen(RGEN.US) With Hold Rating

Moomoo NewsNov 14 07:32 ET

Repligen Initiated With a Peer Perform at Wolfe Research

TipRanksNov 14 06:34 ET

Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207

Moomoo NewsNov 13 08:36 ET

Benchmark Co. Maintains Repligen(RGEN.US) With Hold Rating

Moomoo NewsNov 13 08:36 ET

Repligen (RGEN) Receives a Hold From Benchmark Co.

TipRanksNov 13 08:27 ET

RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $205

Moomoo NewsNov 13 07:35 ET

KeyBanc Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $220

Moomoo NewsNov 12 21:32 ET

Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating

Moomoo NewsNov 12 09:31 ET

Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating

Moomoo NewsNov 11 09:31 ET

Craig-Hallum Remains a Buy on Repligen (RGEN)

TipRanksNov 11 08:37 ET

RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $205

Moomoo NewsOct 24 22:31 ET

J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Cuts Target Price to $190

Moomoo NewsOct 15 08:34 ET

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and Repligen (RGEN)

TipRanksSep 27 08:42 ET

Repligen Analyst Ratings

BenzingaSep 26 10:19 ET